09:49 AM EST - MDS Inc. : said it would sell its MDS Analytical Technologies business to Danaher Corp. for $650 million in cash. On completion of the sale of the MDS Analytical Technologies division, MDS currently plans to return approximately $400 million to $450 million of the sale proceeds to shareholders by way of a share buyback through a Substantial Issuer Bid. In addition, MDS said it now expects to report second-quarter net revenues of about $208 million versus previously reported net revenues of $257 million. For the third quarter of 2009, MDS projects net revenues in the range of $190 million - $195 million. Two analysts polled by Thomson Reuters expect the company to report revenue of $207.36 million for the quarter. MDS Inc.
shares T.MDS are trading up $1.91 at $7.53.
